Efficacy and Safety of OctaplasLG® Administration vs. Crystalloids (Standard) in Patients With Septic Shock - a Randomized, Controlled, Open-label Investigator-initiated Pilot Trial
Phase of Trial: Phase II
Latest Information Update: 22 Jul 2019
Price : $35 *
At a glance
- Drugs Plasma (Primary) ; Ringer's acetate
- Indications Septic shock
- Focus Therapeutic Use
- Acronyms VIPER-SHOCK
- 21 Jul 2019 Status changed from active, no longer recruiting to completed.
- 03 May 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Aug 2018 Biomarkers information updated